The Patent Finder

Sugen, Inc.

Also on record
Records under this name other than patents Sugen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Sugen, Inc.

PatentTitleStatus Expires Confidence
US 7,230,098Aminoheteroaryl Compounds as Protein Kinase Inhibitors
Formerly held
Term ended
Term ended Aug 26, 2025 · High confidence
Term endedTerm ended Aug 26, 2025High confidence
US 6,573,293Pyrrole Substituted 2-Indolinone Protein Kinase Inhibitors
Formerly held
Term ended
Term ended May 22, 2023 · High confidence
Term endedTerm ended May 22, 2023High confidence
US 7,572,924Pyrrole Substituted 2-Indolinone Protein Kinase Inhibitors
Term ended
Term ended Feb 15, 2021 · Low confidence
Term endedTerm ended Feb 15, 2021Low confidence
US 7,211,600Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
Term ended
Term ended Dec 22, 2020 · From the USPTO record
Term endedTerm ended Dec 22, 2020From the USPTO record
US 6,395,734Pyrrole substituted 2-indolinone protein kinase inhibitors
Term ended
Term ended May 28, 2019 · From the USPTO record
Term endedTerm ended May 28, 2019From the USPTO record
US 6,207,401Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
Term ended
Term ended Mar 31, 2019 · From the USPTO record
Term endedTerm ended Mar 31, 2019From the USPTO record
US 6,225,3353-(4'-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
Term ended
Term ended Dec 15, 2018 · From the USPTO record
Term endedTerm ended Dec 15, 2018From the USPTO record
US 7,119,090Pyrrole substituted 2-indolinone protein kinase inhibitors
Lapsed on the fee record
Ended Oct 10, 2018 · From the USPTO record
Lapsed on the fee recordEnded Oct 10, 2018From the USPTO record
US 6,200,341Mechanical heart valve assembly with super-elastic lock wire
Formerly held
Term ended
Term ended Sep 25, 2018 · From the USPTO record
Term endedTerm ended Sep 25, 2018From the USPTO record
US 6,841,579Diagnosis and treatment of AUR1 and/or AUR2 related disorders
Term ended
Term ended Jul 14, 2018 · From the USPTO record
Term endedTerm ended Jul 14, 2018From the USPTO record
10 of 174 patents shown.
Pro members see all 174.
Pro members: see all 174 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited